[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Elana Rosenthal\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":47},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":30,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":46},"100555520","continuum-of-care-in-hospitalized-patients-with-opioidstimulant-use-disorder-and-infectious-complications-from-drug-use-100555520",false,"NCT06513156","Continuum of Care in Hospitalized Patients With Opioid\u002FStimulant Use Disorder and Infectious Complications From Drug Use","Continuum of Care in Hospitalized Patients With Opioid or Stimulant Use Disorder and Infectious Complications of Drug Use - Substance Use\u002FID Integrated Clinic vs. TAU to Prevent Infection Related Readmission","CHOICE-STAR","Inclusion Criteria:\n\n1. Age ≥ 18 years\n2. Admitted to study hospital (defined as hospitalized with a primary team that is not Emergency Medicine)\n3. Injection opioid or stimulant use in past 90 days - per patient self-report\n4. Active suspected or confirmed qualifying infection (see list) at time of admission.\n\nQualifying infections:\n\n* Non-vertebral osteomyelitis\n* Vertebral osteomyelitis or discitis\n* Epidural, subdural, or extradural abscess\n* Intracranial or intraspinal abscess\n* Native joint septic arthritis\n* Prosthetic joint septic arthritis\n* Blood stream infection (bacterial or fungal)\n* Native valve Endocarditis\n* Prosthetic valve endocarditis\n* Cardiac Implantable electronic device infection\n* Infectious pseudoaneurysm and aneurysm\n* Infected vascular graft\n* Septic venous thrombosis\n* Skin and Soft tissue infection (cellulitis, skin abscess, necrotizing fasciitis)\n* Infected skin ulcer\n* Orthopedic hardware infection\n* Muscle abscess\u002Fmyositis\n* Central nervous system infection (bacterial or fungal)\n* Bacterial or fungal ophthalmologic infection\n* Other abscess\n* Pulmonary septic emboli\n* Other acute bacterial or fungal infection deemed appropriate by site study team\n\nExclusion Criteria:\n\n* 1\\. Infection due to a cause other than injection drug use, per determination of a site PI.\n\n  2\\. Inability to provide consent due to circumstance (e.g., sedated, intubated), language, or cognitive impairment.\n\n  3\\. Unwilling to provide informed consent 4. Unable to receive potential interventions due to geography 5. On comfort measures or planned for discharge to hospice care 6. Incarcerated at the time of hospitalization 7. Other criteria at the discretion of the site investigator","ALL","18 Years",{"count":20,"type":21},304,"ESTIMATED","INTERVENTIONAL",[24],"NA","This is a two-group randomized controlled trial conducted at five hospitals across the U.S. designed to test the effectiveness of an Integrated infectious diseases\u002FSubstance Use Disorder outpatient clinic (IC) compared to treatment as usual aimed at reducing infection related readmissions and improving health outcomes in people hospitalized with an infection related to injecting opioids or stimulants.",[27,28,29],"Opioid Use Disorder","Injection Related Infections","Stimulant Use Disorder",[31,32,33,29],"Delivery of Health Care, Integrated","Opioid use disorder","Serious Injection Related Infections","RECRUITING","2025-10-29",{"date":37,"type":38},"2025-10-31","ACTUAL",{"date":40,"type":38},"2024-10-01",{"date":42,"type":21},"2027-07-30",{"name":44,"class":45},"Elana Rosenthal","OTHER",4,""]